Propel Bio Management »

Health Sciences Acq Corp 2 shares owned by Propel Bio Management

Quarter-by-quarter ownership of Health Sciences Acq Corp 2 (OBIO) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Health Sciences Acq Corp 2

Tip: Access up to 7 years of quarterly data

All positions including Health Sciences Acq Corp 2 held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Health Sciences Acq Corp 2 by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.8M 897k 4.27

More positions owned by Propel Bio Management

Plains Gp Hldgs Ltd Partnr Int A (PAGP)
Achieve Life Sciences (ACHV)
Phathom Pharmaceuticals (PHAT)
Delcath Sys Com New (DCTH)
Corcept Therapeutics Incorporated (CORT)
Abeona Therapeutics Com New (ABEO)
Vor Biopharma Com New (VOR)
Kyverna Therapeutics (KYTX)
Milestone Pharmaceuticals (MIST)
Celldex Therapeutics Com New (CLDX)
Compass Pathways Sponsored Ads (CMPS)
Miragen Therapeutics (VRDN)
Inventiva Sa Ads (IVA)
Sab Biotherapeutics Com New (SABS)
Health Sciences Acq Corp 2 (OBIO)

View all positions for Propel Bio Management

Top funds holding Health Sciences Acq Corp 2

Rtw Investments
Perceptive Advisors
Vanguard Capital Management
Vanguard Group
Alyeska Investment Group
Propel Bio Management
Millennium Management
BlackRock
Affinity Asset Advisors
Geode Capital Management
Charles Schwab Investment Management
Knott David M Jr
Vanguard Fiduciary Trust
Simplify Asset Management
683 Capital Management

View all funds holding Health Sciences Acq Corp 2